We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ultra-Fast Test Screens for All Types of Cancer with Simple Blood Draw

By LabMedica International staff writers
Posted on 29 Aug 2024

Cancer can occur at any stage of life, irrespective of age, lifestyle, or genetic background, making early detection critical for effective treatment and better patient outcomes. More...

This underscores a pressing need for improved diagnostic methods in the medical field. Current cancer detection methods face challenges such as limited availability of screening tests, lengthy result processing times, high costs, and invasive procedures. Now, a pioneering technology has been developed that facilitates the early detection of cancer, potentially as early as stage -1, and aids in guiding subsequent imaging tests.

Oncosure (Pompano Beach, FL, USA) has launched its innovative Rapid Cancer Screening Test, democratizing access to early cancer detection. This test, requiring only a single blood draw, is capable of screening for all cancer types, thereby providing reassurance to individuals. Oncosure's cutting-edge screening technology employs rapid in situ hybridization and DNA fluorescent probes to deliver comprehensive and accurate cancer screening. The technology combines a rapid SITU hybridization platform, DNA fluorescent probes for ploidy detection, and cost-effective density gradient and low sequential centrifugation methods to provide thorough screening for aneuploidy across all chromosomes.

The Oncosure test identifies oncosomes—tiny vesicles that are markers of cancer cells—across all types of cancer. Employing advanced fluorescent microscopy, the test ensures precise and actionable outcomes. It offers a swift and dependable method for detecting cancer at very early stages, even stage -1, providing results that are both fast and definitive within a few hours. This enables healthcare providers to make timely decisions. Additionally, the Oncosure test can be instrumental in monitoring the efficacy of ongoing cancer treatments and in providing early detection of cancer recurrence for those in remission, enhancing the chances for successful intervention.

"One blood draw, all cancers—this is the future of cancer screening," said Jason Andrews, Vice President of Oncosure. "Cancer doesn't wait for symptoms, and neither should you. Our test empowers everyone to screen for any type of cancer with a single, non-invasive test."

Related Links:
Oncosure


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Urine Analyzer
respons® UDS100
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.